These courses are intended for internal hospital staff.

Activity Description:

Institute for Limb Preservation® (ILP) is a team of medical professionals specializing in management of complex extremity problems and treatment of conditions and diseases that place people at risk of losing a limb. For more than 30 years, this group—located at Presbyterian/St. Luke's Medical Center (P/SL) and Rocky Mountain Hospital for Children(RMHC)—has established itself as the Rocky Mountain region's premier medical community to evaluate and treat diseases and trauma that affect the extremities. This conference is a comprehensive educational event designed for healthcare professionals focused on advancing knowledge and skills in the prevention, diagnosis, and treatment of limb-threatening conditions. This conference will feature expert-led sessions on cutting-edge techniques in vascular surgery, wound care, and innovative therapies for limb preservation. Attendees will gain valuable insights into multidisciplinary approaches, the latest research, and practical strategies for improving patient outcomes. Participants will also have the opportunity to engage in case discussions, hands-on workshops, and network with leading specialists in the field.

Target Audience:

The intended audience is interventional cardiologists, interventional radiologists, vascular surgeons, general cardiologists, internal medicine physicians, primary care physicians, podiatrists, physician assistants, nurses, cath lab technologists, and all other relevant healthcare providers.

Learning Objectives:

• Discuss comprehensive multidisciplinary best practices for patients in need of advance limb preservation treatment due to peripheral artery disease (PAD) and critical limb ischemia (CLI).
• Examine procedural and technological advances in wound care practices, podiatric treatment, and foot and ankle surgery for patients facing major amputation due to PAD, CLI, non-healing wounds, and gangrene.
• Review medical therapies, surgical options, and endovascular devices available to improve outcomes for patients at risk of major lower extremity amputation.

Moderator: 

David Schnur, MD

David Hahn, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.